The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > diaDexus, Inc.

diaDexus, Inc.
 PROFILE
diaDexus works to detect deadly diseases. The company uses raw genomics data to develop diagnostic tests for such conditions as coronary heart disease, osteoporosis, and colorectal, breast, and other cancers. Lead products in development include Lp-PLA(2) for coronary heart disease and Cathepsin-K for osteoporosis. diaDexus also plans to develop therapeutics with a focus on monoclonal antibodies, which target disease-associated proteins found on the surface of cells. diaDexus was founded by genomics leaders SmithKline Beecham (now GlaxoSmithKline) and Incyte Genomics, which provide it with genomic data and potential molecular targets; each owns roughly 20% of the company.

 COMPETITION
Abbott Laboratories (ABT)
Millennium Pharmaceuticals, Inc. (MLNM)
Myriad Genetics, Inc. (MYGN)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 0.10
Employees: 36
Revenue per employee: $2,777.78

 KEY PEOPLE
• Patrick Plewman
    CEO
• Sharon E. Tetlow
    CFO

 CONTACT INFO
3303 Octavius Dr.
Santa Clara, CA 95054
US
Phone: 408-496-6600
Fax: 408-496-5777
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001